On March 1, 2024, Applied Therapeutics, Inc. closed the transaction. The company has received $99,997,998 from 31 investors pursuant to exemption provided under Regulation D. The company has paid $7,499,850 sales commissions in the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.29 USD | -2.50% | +5.15% | +28.06% |
May. 09 | Applied Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 09 | Earnings Flash (APLT) APPLIED THERAPEUTICS Posts Q1 Revenue $190,000 | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
33.5 USD | +1.03% | -2.56% | 5.37B | ||
4.29 USD | -2.50% | +5.15% | 489M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.06% | 489M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- APLT Stock
- News Applied Therapeutics, Inc.
- Applied Therapeutics, Inc. announced that it has received $99.997998 million in funding from a group of investors